![]() |
|
|
Vol. 31, Issue 4, 447-451, April 2003
Merck Frosst Centre for Therapeutic Research and Co.,
Montréal, Québec, Canada (R.H., J.R., J-F.L., D.A.N.-G.,
J.M.S.); Departments of Pharmaceutical Sciences and Pharmacology,
University of Toronto, Toronto, Ontario, Canada (K.S.P.); Department of
Pharmacology, Dalhousie University, Nova Scotia, Canada (J.R.)
The success of cryopreservation of isolated hepatocytes with
existing methodologies is assessed with respect to the retentivity of
cell integrity/viability (defined by trypan blue) and metabolic activities upon thawing in comparison to those of freshly prepared cells. But the ability of the cryopreserved cells to transport xenobiotics relative to that of freshly prepared cells has not been
investigated. In this study, we optimized our previous methodology for
cryopreservation and evaluated the metabolism and transport of thawed
hepatocytes. Half of the freshly, isolated rat hepatocytes prepared by
collagenase perfusion were immediately used for studies of transport of
[14C]taurocholate, [3H]estrone sulfate and
[3H]estradiol 17
-D-glucuronide (1 µM)
and metabolism of 7-hydroxy-4-(trifluoromethyl)-coumarin (100 µM),
(3,4-difluorobenzyloxy)-5,5-dimethyl-4-(4-methylsulfonylphenyl)-(5H)-furan-2-one (250 µM), bufuralol (100 µM), and tolbutamide (100 µM), probes for UDP-glucuronyl transferase (UGT) and CYP3A, CYP2D, and CYP2C, respectively. The remaining half was cryopreserved using an optimized, programmed-freezing protocol, which was developed to minimize the
prolonged release of latent heat during freezing. With the exception of
the UGT probe, no significant difference (P > 0.05) was found in both metabolism and transport with freshly isolated versus cryopreserved hepatocytes upon thawing. In conclusion, we have
demonstrated for the first time that thawed rat hepatocytes cryopreserved by a programmed-freezing protocol retain drug transport activities.
This article has been cited by other articles:
![]() |
M. Grondin, F. Hamel, F. Sarhan, and D. A. Averill-Bates Metabolic Activity of Cytochrome P450 Isoforms in Hepatocytes Cryopreserved with Wheat Protein Extract Drug Metab. Dispos., October 1, 2008; 36(10): 2121 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Brown, M. Griffin, and J. B. Houston Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic Clearance Drug Metab. Dispos., February 1, 2007; 35(2): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-a. Bi, D. Kazolias, and D. B. Duignan Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport Drug Metab. Dispos., September 1, 2006; 34(9): 1658 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. McGinnity, M. G. Soars, R. A. Urbanowicz, and R. J. Riley EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE Drug Metab. Dispos., November 1, 2004; 32(11): 1247 - 1253. [Abstract] [Full Text] [PDF] |
||||